Clinical Trials Test Treatments For Drug-Resistant TB, Vaccine To Prevent Disease

Devex: Georgia trials could revolutionize treatment of drug-resistant TB
“As world leaders gear up for a landmark United Nations meeting on tuberculosis this week, two pivotal trials in the small Eurasian country of Georgia are promising to break new ground in the fight against multidrug-resistant TB…” (Edwards, 9/26).

Reuters: GSK vaccine success a milestone in TB, but room for improvement
“An experimental GlaxoSmithKline vaccine could prevent tuberculosis developing in half of those who receive it, making it potentially the first new shot against the global killer in a century, researchers said on Tuesday…” (Hirschler, 9/25).

Science News: A new vaccine raises hopes of someday curbing the tuberculosis epidemic
“…The results were reported online September 25 in the New England Journal of Medicine, a day before the United Nations General Assembly’s first high-level meeting on ending tuberculosis…” (Cunningham, 9/25).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.